ORX:STO
Orexo AB
0,88 SEK
arrow_upward
+1,27%(+0,011) 1D
13 қар., 17:29:57 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
0,90 SEK
High
0,90 SEK
Low
0,83 SEK
Mkt. cap
306,65 млн
Avg. vol.
739,90 м.
Volume
1,15 млн
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
0,90 SEK
High
0,90 SEK
Low
0,83 SEK
Mkt. cap
306,65 млн
Avg. vol.
739,90 м.
Volume
1,15 млн
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
24/7 Wall St.
·
19 минут бұрын
The S&P 500 Has a "Pure Value" Version. RPV Gives Its Cheapest Stocks the Biggest Weights
TradingNEWS
·
20 минут бұрын
Stock Market Today: S&P 500 7,510 (-1.1%), Nasdaq -1.9%, Dow DJI -0.3%; 7,845 Target as AMD -9.7%
24/7 Wall St.
·
18 минут бұрын
S&P 500 Slides Nearly 1% at Midday as Tech Absorbs Most of the Hit
TradingView
·
3 сағат бұрын
Wall Street Divided on S&P 500: Which ETFs Could Benefit in 2027?
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com